Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Boer

Showing results (31-40 of 157) with videos related to

Pageof 16
Sort By:
Pharmacology|January 1, 1988
Does the prolonged occupancy of M1 receptors by telenzepine protect them against the action of vagally released acetylcholine?C Schudt, C Auriga, N J Birdsall, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 14, 2012
Chapter 7: Description of MISCAN-lung, the Erasmus MC Lung Cancer microsimulation model for evaluating cancer control interventionsF W Schultz, R Boer, H J de Koning
Developmental Pharmacology and Therapeutics|January 1, 1984
The influence of asphyxia on phenobarbital dosing requirements in neonatesP Gal, J Toback, N V Erkan, et al.
Neurology|July 1, 1982
Phenobarbital dosing in neonates and asphyxiaP Gal, H R Boer, J Toback, et al.
European Journal of Pharmacology|April 13, 1984
Interactions of vasopressin agonists and antagonists with membrane receptorsF Fahrenholz, R Boer, P Crause, et al.
European Journal of Biochemistry|May 31, 1990
Monoclonal antibodies against different epitopes of peptide hormones. Use of photoreactive analogues in studies on vasopressinM Jurzak, R Boer, G Fritzsch, et al.
JAMA|January 10, 1996
Cost-effectiveness of mammography screeningR Boer, G J van Oortmarssen, H J de Koning
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1990
Characterization of the muscarine receptor type on paracrine cells activated by McN-A-343 in the mouse isolated stomachW Kromer, E Baron, M Beinborn, et al.
Journal of the National Cancer Institute|October 19, 2000
Re: improving the cost-effectiveness of colorectal cancer screeningF Loeve, M L Brown, R Boer, et al.
Drugs|January 1, 1990
Central and peripheral hypotensive activity of urapidil and its M1 and M2 metabolites in the catH Boss, R Boer, K D Beller, et al.
Pageof 16

Showing results (31-40 of 157) with videos related to

Sort By:
Pageof 16
Pharmacology|January 1, 1988
Does the prolonged occupancy of M1 receptors by telenzepine protect them against the action of vagally released acetylcholine?C Schudt, C Auriga, N J Birdsall, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 14, 2012
Chapter 7: Description of MISCAN-lung, the Erasmus MC Lung Cancer microsimulation model for evaluating cancer control interventionsF W Schultz, R Boer, H J de Koning
Developmental Pharmacology and Therapeutics|January 1, 1984
The influence of asphyxia on phenobarbital dosing requirements in neonatesP Gal, J Toback, N V Erkan, et al.
Neurology|July 1, 1982
Phenobarbital dosing in neonates and asphyxiaP Gal, H R Boer, J Toback, et al.
European Journal of Pharmacology|April 13, 1984
Interactions of vasopressin agonists and antagonists with membrane receptorsF Fahrenholz, R Boer, P Crause, et al.
European Journal of Biochemistry|May 31, 1990
Monoclonal antibodies against different epitopes of peptide hormones. Use of photoreactive analogues in studies on vasopressinM Jurzak, R Boer, G Fritzsch, et al.
JAMA|January 10, 1996
Cost-effectiveness of mammography screeningR Boer, G J van Oortmarssen, H J de Koning
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1990
Characterization of the muscarine receptor type on paracrine cells activated by McN-A-343 in the mouse isolated stomachW Kromer, E Baron, M Beinborn, et al.
Journal of the National Cancer Institute|October 19, 2000
Re: improving the cost-effectiveness of colorectal cancer screeningF Loeve, M L Brown, R Boer, et al.
Drugs|January 1, 1990
Central and peripheral hypotensive activity of urapidil and its M1 and M2 metabolites in the catH Boss, R Boer, K D Beller, et al.
Pageof 16